Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade

We determined whether prostate specific antigen (PSA) would decrease with immediate antiandrogen switching from bicalutamide (BCL) to flutamide (FLT) in patients receiving combined androgen blockade for advanced prostate cancer. From 2002 to 2006, 20 patients who showed PSA failure after first-line...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Yokomizo, Yumiko, Kawahara, Takashi, Miyoshi, Yasuhide, Otani, Masako, Yamanaka, Shoji, Teranishi, Jun-ichi, Noguchi, Kazumi, Yao, Masahiro, Uemura, Hiroji
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2016
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963562/
https://ncbi.nlm.nih.gov/pubmed/27493956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4083183
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы